Newtyn Management »

Indivior Pharmaceuticals shares owned by Newtyn Management

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Newtyn Management from 13F filings

Historical chart of Newtyn Management investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Newtyn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Newtyn Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $61M 2.0M 30.48

More positions owned by Newtyn Management

Harsco Corporation (NVRI)
Theravance Biopharma (TBPH)
Quidel Corp (QDEL)
United States Cellular Corporation (AD)
Commscope Hldg (VISN)
Indivior Pharmaceuticals (INDV)
Apartment Invt & Mgmt Cl A (AIV)
Teleflex Incorporated (TFX)
Resolute Hldgs Mgmt (RHLD)
Cannae Holdings (CNNE)
PAR Technology Corporation (PAR)
USA Rare Earth Inc A (USAR)
Weave Communications (WEAV)
Cogent Comm Holdings Com New (CCOI)
Magnera Corp Com Shs (MAGN)

View all positions for Newtyn Management

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals